Exploring centre variation in RRT provision Dr Clare Castledine UKRR clinical fellow.

Slides:



Advertisements
Similar presentations
Social deprivation, ethnicity and access to kidney transplantation in England and Wales Udaya Udayaraj.
Advertisements

Variation in home dialysis in the UK Dr Clare Castledine Registrar UKRR UK Renal Registry 2011 Annual Audit Meeting.
The future of haemodialysis in the UK RCP advanced medicine 2013 Cormac Breen Consultant Nephrologist Guy's and St Thomas' Hospitals London.
Reference Avram MM, et al. Hemoglobin predicts long-term survival in dialysis patients: a 15-year single-center longitudinal study and a correlation trend.
Slough Diabetes Improvement Programme Right Care approach 11 th & 18 th March 2015 Dr. Nithya Nanda, Diabetes GP Lead Slough CCG 1 SLOUGH Clinical Commissioning.
¡Celebremos La Salud!: A cancer prevention program for Hispanic and non-Hispanic White women living in a rural area Silvia Tejeda, MPH Doctoral Candidate.
UK Renal Registry 16th Annual Report Figure 8.1. Trend in 1 year after 90 day incident patient survival by first modality, 2005–2011 cohort (adjusted to.
UK Renal Registry 16th Annual Report Figure Median haemoglobin for incident dialysis patients at start of dialysis treatment in 2012.
UK Renal Registry 14th Annual Report Figure 8.1. Median haemoglobin for incident dialysis patients at start of dialysis treatment in 2010.
Use of clinical laboratory databases to enable early identification of patients at highest risk of developing end- stage kidney disease Dr David Kennedy.
Chronic kidney disease Mr James Hollinshead Public Health Analyst East Midlands Public Health Observatory (EMPHO) UK Renal Registry 2011 Annual Audit Meeting.
UKRR Annual Informatics Meeting, September 2013 Highlights from the 15 th Annual Report Rishi Pruthi Research Fellow UK Renal Registry.
Peritoneal Dialysis for Elderly Patients: A Review Source: Tesar V. Peritoneal dialysis in the elderly—is its underutilization justified? Nephrol Dial.
SOCIO-ECONOMIC STATUS AND MORTALITY FROM CARDIOVASCULAR DISEASE AMONG PEOPLE WITH TYPE 2 DIABETES IN SCOTLAND ( ) Caroline Jackson, Jeremy Walker,
Section G – Special Projects Scottish Renal Registry Report 2008 Published by the Information Services Division (ISD Scotland), Common Services Agency.
Improving the utility of comorbidity records Retha Steenkamp UK Renal Registry.
Why your data matters? How it helps patients, the NHS and research? How do I get UKRR data for research? Dr Retha Steenkamp Senior Statistician, UKRR.
Quality Measurement and Gender Differences in Managed Care Populations with Chronic Diseases Ann F. Chou Carol Weisman Arlene Bierman Sarah Hudson Scholle.
Information, Quality and Values Donal O’Donoghue National Clinical Director for Kidney Care Working for better kidney care UKRR and NHS Kidney Care Information.
Data completeness reporting Alex Hodsman, David Bull, Paul Dawson UK Renal Registry.
UK Renal Registry 17th Annual Report Figure 2.1. Prevalence rates per million population by age group and UK country on 31/12/2013.
UK Renal Registry 10th Annual Report 2007 Fig 3.1 Incident rates in the countries of the UK:
UK Renal Registry 17th Annual Report Figure 1.1. RRT incidence rates in the countries of the UK 1990–2013.
Urban-Rural Inequalities in Potentially Preventable Hospital Admissions Carolyn Hunter-Rowe Senior Health Intelligence Analyst Department of Public Health.
UK Renal Registry 10th Annual Report 2007 Fig 8.1 Median haemoglobin for incident dialysis patients at start of dialysis treatment.
Highlights from the Annual Report UK Renal Registry 2013 Annual Audit Meeting Dr Catriona Shaw Registrar, UK Renal Registry.
Survival after graft failure Dr Lynsey Webb Registrar UK Renal Registry UK Renal Registry 2011 Annual Audit Meeting.
UK Renal Registry 15th Annual Report Figure 6.1. Median haemoglobin for incident dialysis patients at start of dialysis treatment in 2011.
Serum Aluminium monitoring in 16,530 dialysis patients in England and Wales: compliance with national guidelines? Udaya P Udayaraj 1, E J Lamb 2, R.Steenkamp.
10 points. Diabetes Practice Profile 2011
Introduction to Disease Prevalence modelling Day 6 23 rd September 2009 James Hollinshead Paul Fryers Ben Kearns.
The Databases: Successes and Shortcomings in Renal Replacement Therapy Since 1989 European Renal Association and European Dialysis and Transplant Association.
UK Renal Registry 14th Annual Report Figure Consort diagram detailing incident RRT patients 2002–2006, HES admissions and ONS records included in.
UK Renal Registry 10th Annual Report 2007 Fig 9.1 Annual change in percentage of dialysis patients with serum phosphate < 1.8mmol/L and ≥1.1 -≤1.8mmol/L.
What happens to patients returning to dialysis after transplant failure? Data from the UK Renal Registry Dr Lynsey Webb 1, Dr Anna Casula 1, Dr Charlie.
Chronic kidney disease prevalence model October 2014 Gateway number
North West Surrey CCG Health Profile Health Profile Summary Population – current, projected & specific groups Wider determinants Health behaviours.
Denise Kendrick University of Nottingham.  Inequality or inequity?  Differences in injury risk ◦ Child factors ◦ Family factors ◦ Social factors ◦ Environmental.
Is it possible to predict New Onset Diabetes After Transplantation (NODAT) in renal recipients using epidemiological data alone? Background NODAT is an.
Diabetes Health Intelligence A Summary of Information: South Central SHA.
Surrey Downs CCG Health Profile Health Profile Summary Population – current, projected & specific groups Wider determinants Health behaviours Disease.
Obesity in the end stage kidney disease population
Associate Professor, Honorary Consultant Cardiologist
Hypertension November 2016
First-year death rates by modality figure 8
Optimization of pre-ESRD care: The key to improved dialysis outcomes
ART and toxicities: CNS
Baseline Demographic and Clinic Variables According to Office vs 24-Hour or Home BP Giuseppe Mancia, et al. Hypertension 2006;47;
Volume 68, Pages S46-S52 (August 2005)
A “Scottish effect” for health?
UK Renal Registry 16th Annual Report
UK Renal Registry 18th Annual Report
UK Renal Registry 9th Annual Report 2006
UK Renal Registry 10th Annual Report 2007
UK Renal Registry 19th Annual Report
Annie-Claire Nadeau-Fredette
North west Regional Day
Dr Stephanie Jones, Dr Amal Khanolkar, Dr Krystyna Matyka,
UK Renal Registry 14th Annual Report
UK Renal Registry 16th Annual Report
Volume 68, Pages S46-S52 (August 2005)
Hypertension November 2016
UK Renal Registry 16th Annual Report
Fig 7.1 Median URR achieved in each centre, 2006
UK Renal Registry 16th Annual Report
Optimization of pre-ESRD care: The key to improved dialysis outcomes
Dialysis outcomes in Australia & New Zealand
Percentage of individuals aged 16 and over taking cardiovascular-related prescriptions, by sex, England 2012–2013. Percentage of individuals aged 16 and.
Thirty-day crude mortality (%) and adjusted weekend admission ORs (±95% CI): effect of non-availability of NEWS, increasing NEWS band and ICU transfer.
Determinants of moderate Cardiovascular Health Index Score (achieving three or more risk factor targets), stratified by region conventions as in figure.
Presentation transcript:

Exploring centre variation in RRT provision Dr Clare Castledine UKRR clinical fellow

Aims: 1. Variation in RRT incidence 2. Variation in proportion on home dialysis modalities (Peritoneal Dialysis and Home Haemodialysis)

RRT incidence Variation in RRT incidence rate in England and Wales Reproduced from J Epidemiol Community Health Udaya Udayaraj et al,64: , copyright 2010 with permission from BMJ Publishing Group Ltd.

Variation in RRT incidence rate in England and Wales After further adjustment for ethnicity and socio-economic deprivation… Significantly higher rates in Wales Significantly lower rates in Yorkshire and North West

Next step Variation could be due to: –A) Differences –Demographic and health status of the population at risk –B) Disparities –Differences in availability/organisation of healthcare resources –C) Bias –Patients beliefs, physician beliefs Rathore SS, Krumholz HM. Differences, Disparities, and Biases: Clarifying Racial Variations in Health Care Use.Ann Intern Med :

Next step Variation could be due to: –A) Differences –Demographic and health status of the population at risk –B) Disparities –Differences in availability/organisation of healthcare resources –C) Bias –Patients beliefs, physician beliefs Rathore SS, Krumholz HM. Differences, Disparities, and Biases: Clarifying Racial Variations in Health Care Use.Ann Intern Med :

Next step Variation could be due to: –A) Differences General population diabetes prevalence General population hypertension prevalence Life expectancy Cardio-vascular mortality rates Proportion of diabetics achieving good glycaemic control (HbA1c<7.5%) Proportion hypertensive achieving moderate BP control (150/90)

Next step Variation could be due to: –A) Differences –Demographic and health status of the population at risk –B) Disparities –Differences in availability/organisation of healthcare resources –C) Bias –Patients beliefs, physician beliefs

Next steps Variation could be due to: –B) Disparities angioplasty/CABG rates take up of mammography screening hip replacement rates

Next step Variation could be due to: –B) Disparities angioplasty/CABG rates take up of mammography screening hip replacement rates National Renal Unit Survey

National Survey Systematic literature search 11 variables identified relating to RRT incidence 15 variables identified relating to modality mix 2 round Delphi consensus technique 14 additional variables suggested relating to RRT incidence 12 additional variables suggested relating to modality mix National Survey developed from: 10 highest ranking variables relating to RRT incidence 10 highest ranking variables relating to PD penetrance 10 highest ranking variables relating to HHD penetrance

National Survey Systematic literature search 11 variables identified relating to RRT incidence 15 variables identified relating to modality mix 2 round Delphi consensus technique 14 additional variables suggested relating to RRT incidence 12 additional variables suggested relating to modality mix National Survey developed from: 10 highest ranking variables relating to RRT incidence 10 highest ranking variables relating to PD penetrance 10 highest ranking variables relating to HHD penetrance Response rate so far…89%

Methods Ecological study –Measurement level PCT/Health Board (n=192) –Median population 250,000 (IQR184, ,000) RRT incidence for 2007 and 2008 for each PCT/Health Board Incident patients = 6642 –Median rate : 112 pmp (IQR pmp)

General population Number (N) observations Median (IQR) Townsend socio-economic deprivation score (SES) ( ) Ethnic origin (% non white) ( ) Prevalence diabetes(%) ( ) Prevalence hypertension (%) ( ) % achieving Hba1c <7.5% ( ) % achieving BP<150/ ( ) Life expectancy at birth (years) years ( ) Cardiovascular mortality pmp ( )

General population Number (N) observations Median (IQR) Townsend socio-economic deprivation score (SES) ( ) Ethnic origin (% non white) ( ) Prevalence diabetes(%) ( ) Prevalence hypertension (%) ( ) % achieving Hba1c <7.5% ( ) % achieving BP<150/ ( ) Life expectancy at birth (years) years ( ) Cardiovascular mortality pmp ( )

General population Number (N) observations Median (IQR) Townsend socio-economic deprivation score (SES) ( ) Ethnic origin (% non white) ( ) Prevalence diabetes(%) ( ) Prevalence hypertension (%) ( ) % achieving Hba1c <7.5% ( ) % achieving BP<150/ ( ) Life expectancy at birth (years) years ( ) Cardiovascular mortality pmp ( )

General population Number (N) observations Median (IQR) Townsend socio-economic deprivation score (SES) ( ) Ethnic origin (% non white) ( ) Prevalence diabetes(%) ( ) Prevalence hypertension (%) ( ) Percentage achieving Hba1c <7.5% 188 (NI excluded) 59.6 ( ) Percentage achieving BP<150/ ( ) Life expectancy at birth (years) years ( ) Cardiovascular mortality (pmp) pmp ( )

Univariate correlation diabetes prevalence and RRT incidence

Results-diabetes prevalence Poisson model adjustments Incidence rate ratio of RRT Unadjusted (95% CI) Incidence rate ratio of RRT Adjusted age, gender, ethnicity and SES (95% CI) QOF diabetes prevalence 1.20 ( p<0.0001) 1.08 ( p=0.008) Modeled diabetes prevalence 1.24 ( p<0.0001) 1.11 ( p=0.001)

Results-hypertension prevalence Poisson model adjustments Incidence rate ratio of RRT Unadjusted (95% CI) Incidence rate ratio of RRT adjusted for age, gender, ethnicity and SES (95% CI) QOF Hypertension prevalence 0.98 ( p=0.001) 1.03 ( p=0.023) QOF hypertension control 0.99 ( p=0.026) 1.00 ( p=0.795)

Results Poisson model adjustments Incidence rate ratio of RRT Unadjusted (95% CI) Incidence rate ratio of RRT adjusted for age, gender, ethnicity and SES (95% CI) Life expectancy at birth 0.91 ( p<0.0001) 0.95 ( p=0.006) Cardio-vascular mortality 1.09 ( p<0.0001) 1.05 ( p=0.017)

The correlation between the actual RRT incidence and the incidence predicted from the model

The observed/expected RRT incidence for each PCT/Health Board 2007 and 2008

The observed/expected RRT incidence for each PCT/Health Board 2007 and 2008

The observed/expected RRT incidence for each PCT/Health Board 2007 and 2008

Summary Each % point rise in diabetes in an area was associated with an 8% rise in RRT rate Each % point rise in hypertension in an area was associated with a 3% rise in RRT rate Each standard deviation higher life expectancy was associated with a 5% decrease in RRT incidence rate Each standard deviation higher CV mortality in an area was associated with a 5% increase in RRT incidence rate 64% variance explained with these health status and demographic factors……the remaining with renal survey factors

Acknowledgements Many thanks to: –Fergus Caskey –Julie Gilg –All the renal units and SRR for sending us data –Everyone who completed the survey